SYNVET-50; 50 MG SOLUTION FOR INJECTION FOR HORSES.
Land: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Vara einkenni
(SPC)
30-10-2015
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
HYALURONATE SODIUM
Fáanlegur frá:
Equimed Europe Ltd
ATC númer:
QM09AX01
INN (Alþjóðlegt nafn):
HYALURONATE SODIUM
Skammtar:
50 Milligram
Lyfjaform:
Sterile Solution
Gerð lyfseðils:
VPO-Vet.Practitioner Only
Meðferðarhópur:
Equine - Food
Lækningarsvæði:
Hyaluronic acid
Ábendingar:
Miscellaneous
Leyfisstaða:
Authorised
Leyfisdagur:
2014-07-18
Vara einkenni
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
SynVet-50; 50 mg solution for injection for horses.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
Clear colourless viscous solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horse.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For adjunctive intra-articular treatment of joint disease associated with non-infectious synovitis in horses.
4.3 CONTRAINDICATIONS
Do not use in case of joint infections.
Do not use in case of known hypersensitivity to exogenous sodium hyaluronate
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The treated horse should be box-rested for 2 days before gradually resuming a normal exercise pattern.
4.5 SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Excess synovial fluid should be removed whenever possible prior to injection.
The injection should be administered under strict aseptic conditions through healthy undamaged skin.
Appropriate investigations should be carried out in cases of acute, severe lameness to ensure that the joints are free
from fractures, OCD fragments and infections.
II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
In case of accidental contact with skin, wash with soap and water.
In case of accidental contact with eyes, blurred vision may occur because of the viscous nature of the product. Rinse
immediately with plenty of clean water.
In the event of accidental self injection, seek medical advice.
ACTIVE SUBSTANCE:
Each 2.5 ml syringe contains:
Sodium Hyaluronate
50 mg
(equivalent to hyaluronic acid)
47 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
HEALTH PRODUCTS REGULATORY AUTHORITY
_____________________________________________
Lestu allt skjalið
